�㽶��Ƶ

Thomas Varghese Jr. becomes the eighth Editor-in-Chief during the 119-year history of the JACS, where he will be tasked with driving innovation and inspiring the next generation of surgical pioneers.

Mobile mammography buses from Huntsman Cancer Institute and Nevada Health Centers join forces to conquer distance as a disparity, offering Wendover residents vital breast cancer screenings.

The National Cancer Institute recognized Huntsman Cancer Institute investigator Minna Roh-Johnson for excellence in diversity, equity, inclusion, and accessibility. Roh-Johnson explains the importance of mentorship and diversity in scientific research.

Huntsman Family Foundation is honored with the Spirit of Giving Award for their commitment to support those affected by cancer and other health challenges. Learn about their impactful contributions.

A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved overall survival rates for metastatic prostate cancer compared to standard treatments.

Explore how Huntsman Cancer Institute's 25-year legacy of excellence is reaching new heights and advancing cancer treatments of the future beyond the standard of care today.

Demand for cancer genetic testing is on the rise, but there’s a national shortage of genetic counselors to guide patients through the process. Researchers say chatbots could be the answer.

Study shows new method forecasts the severity of a patient’s diagnosis and its likelihood of recurrence. This latest information should improve treatment and offers hope by potentially saving countless lives.

Landmark survey illustrates the care barriers that rural and frontier communities face throughout the Mountain West. This groundbreaking work helps Huntsman Cancer Institute address these disparities more effectively.

Heloisa Soares, MD, PhD, and Skyler Johnson, MD, were selected as members of The Society of Huntsman Translational Scholars for their contributions to advancing cancer research and patient care.

Early menopause significantly raises breast cancer risk, highlighting the need for proactive health screenings, according to research from Huntsman Cancer Institute and the Spencer Fox Eccles School of Medicine.

Huntsman Cancer Institute and the Price College of Engineering have selected six teams to receive collaborative grants for a new program that aims to find solutions for cancer problems.

Women with endometriosis are four times more likely to develop ovarian cancer, and those with more severe cases are at an even greater risk.

The interdisciplinary team of lung cancer researcher Michelle Mendoza and biomedical engineer Jeffrey Weiss have received a multimillion dollar grant to study the origin of malignant tumors in the lungs.

Researchers have designed new digital tools that have quadrupled screening rates for patients at high risk for lung cancer.

Kim Kaphingst, ScD; June Round, PhD; and Neli Ulrich, PhD, MS, have been recognized by the �㽶��Ƶ of Utah for their exemplary work in cancer research.

David Wetter, PhD, has been honored for pioneering cancer health equity strategies, transforming research into practical solutions, and fostering vital community partnerships for underserved populations and rural communities.

A special award celebrates Huntsman Cancer Institute’s plan to establish a comprehensive cancer center in Vineyard, bringing crucial cancer research and care closer to more communities in the region.

Neli Ulrich joins a select group of recipients recognized for their impactful work in science and technology in Utah.

A study by Joemy Ramsay, PhD, suggests families with infertile male relatives may face elevated cancer risks. Tapping into genetic data, families could help personalize cancer risk assessments.

Suneja’s work focuses on diversifying the scientific workforce and reducing barriers for clinical trial research patient participation.

The Utah Legislature’s $75 million allocation propels Huntsman Cancer Institute’s plan for a second comprehensive cancer center, advancing research and care. Discover how this initiative brings hope and progress.

Using a new platform, Jonathan Constance, PhD, researcher at Huntsman Cancer Institute, studies commonly prescribed medications in hopes of creating more effective treatments for pediatric cancer patients.

Researchers found tumors release a protein that triggers an immune attack on brain cells, which causes rapid cognitive decline. This discovery could lead to new treatments for this serious complication.